Annual EBITDA
$1.25B$499.00M+66.18%
Summary
- Current Value
- As of today, ILMN annual EBITDA is $1.25B, up +66.18% on
- Historical Performance
- ILMN annual EBITDA is up +67.51% over the past 3 years, up +63.36% over the past 5 years
- All-Time High Comparison
- ILMN annual EBITDA is currently at its all-time high
- 3-Year Low Comparison
- ILMN annual EBITDA is +270.71% above its 3-year low of $338.00M reached on
- Sector Comparison
- ILMN annual EBITDA is higher than 93.99% of companies in Healthcare sector
EBITDA Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $1.25B | +66.2% | +67.5% | +63.4% | +412.2% | |
| Quarterly EBITDA | $263.00M | +4.0% | +511.6% | +9.1% | +191.7% | |
| TTM EBITDA | $1.18B | -32.2% | +95.2% | +52.0% | +308.7% | |
| Price | $143.24 | +83.2% | -29.4% | -61.4% | +93.1% | |
| PE Ratio | 26.00 | – | – | -70.0% | -69.9% | |
| Annual Revenue | $4.34B | -0.4% | -5.4% | +33.9% | +380.5% | |
| Annual EPS | $5.45 | +170.8% | +119.4% | +22.9% | +526.3% | |
| $983.00M | +145.8% | +177.7% | +69.5% | +385.2% | ||
| Annual Net Income | $850.00M | +169.5% | +119.3% | +29.6% | +580.6% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $1.25B | at high | |
| 5Y | $1.25B | at high | |
| All | $1.25B | at high |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $338.00M | +270.7% | |
| 5Y | $338.00M | +270.7% | |
| All | -$29.27M | +4380.5% |
EBITDA History
FAQ
What is the current annual EBITDA of ILMN?
As of today, ILMN annual EBITDA is $1.25B
What is 1-year change in ILMN annual EBITDA?
ILMN annual EBITDA is up +66.18% year-over-year
What is 3-year change in ILMN annual EBITDA?
ILMN annual EBITDA is up +67.51% over the past 3 years
How far is ILMN annual EBITDA from its all-time high?
ILMN annual EBITDA is currently at its all-time high
How does ILMN annual EBITDA rank versus sector peers?
ILMN annual EBITDA is higher than 93.99% of companies in Healthcare sector
When is ILMN next annual earnings release?
As of today, the next annual earnings release for ILMN has not been scheduled
Quarterly EBITDA
$263.00M$61.00M-18.83%
Summary
- Current Value
- As of today, ILMN quarterly EBITDA is $263.00M, down -18.83% on
- Historical Performance
- ILMN quarterly EBITDA is up +3.95% year-over-year, up +511.63% over the past 3 years
- All-Time High Comparison
- ILMN quarterly EBITDA is currently -57.44% below its historical high of $618.00M set on
- 3-Year Low Comparison
- ILMN quarterly EBITDA is +721.88% above its 3-year low of $32.00M reached on
- Sector Comparison
- ILMN quarterly EBITDA is higher than 93.10% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $263.00M | -18.8% | +4.0% | +511.6% | +9.1% | |
| Annual EBITDA | $1.25B | – | +66.2% | +67.5% | +63.4% | |
| TTM EBITDA | $1.18B | +0.9% | -32.2% | +95.2% | +52.0% | |
| Price | $143.24 | +22.6% | +83.2% | -29.4% | -61.4% | |
| PE Ratio | 26.00 | +21.6% | – | – | -70.0% | |
| Quarterly Revenue | $1.09B | -6.0% | +4.8% | +0.4% | -0.2% | |
| Quarterly EPS | $0.87 | -59.9% | +5.6% | +4479.5% | -13.0% | |
| $232.00M | -9.7% | +26.1% | +462.5% | +20.2% | ||
| Quarterly Net Income | $134.00M | -59.9% | +2.3% | +4366.7% | -8.8% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $324.00M | -18.8% | |
| 3Y | $618.00M | -57.4% | |
| 5Y | $618.00M | -57.4% | |
| All | $618.00M | -57.4% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $253.00M | N/A | +4.0% |
| 3Y | $32.00M | +721.9% | |
| 5Y | -$480.00M | +154.8% | |
| All | -$480.00M | +154.8% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of ILMN?
As of today, ILMN quarterly EBITDA is $263.00M
What is ILMN quarterly EBITDA most recent change?
ILMN quarterly EBITDA was down -18.83% on March 29, 2026
What is 1-year change in ILMN quarterly EBITDA?
ILMN quarterly EBITDA is up +3.95% year-over-year
How far is ILMN quarterly EBITDA from its all-time high?
ILMN quarterly EBITDA is currently -57.44% below its historical high of $618.00M set on September 29, 2024
How does ILMN quarterly EBITDA rank versus sector peers?
ILMN quarterly EBITDA is higher than 93.10% of companies in Healthcare sector
When is ILMN next earnings release?
The next earnings release for ILMN is on
TTM EBITDA
$1.18B$10.00M+0.86%
Summary
- Current Value
- As of today, ILMN TTM EBITDA is $1.18B, up +0.86% on
- Historical Performance
- ILMN TTM EBITDA is down -32.20% year-over-year, up +95.18% over the past 3 years
- All-Time High Comparison
- ILMN TTM EBITDA is currently -32.20% below its historical high of $1.73B set on
- 3-Year Low Comparison
- ILMN TTM EBITDA is +250.75% above its 3-year low of $335.00M reached on
- Sector Comparison
- ILMN TTM EBITDA is higher than 93.56% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $1.18B | +0.9% | -32.2% | +95.2% | +52.0% | |
| Annual EBITDA | $1.25B | – | +66.2% | +67.5% | +63.4% | |
| Quarterly EBITDA | $263.00M | -18.8% | +4.0% | +511.6% | +9.1% | |
| Price | $143.24 | +22.6% | +83.2% | -29.4% | -61.4% | |
| PE Ratio | 26.00 | +21.6% | – | – | -70.0% | |
| TTM Revenue | $4.39B | +1.1% | +1.3% | -1.3% | +26.4% | |
| TTM EPS | $5.51 | +0.8% | +190.3% | +119.3% | +28.9% | |
| $942.00M | +5.4% | -33.6% | +388.1% | +61.6% | ||
| TTM Net Income | $853.00M | +0.3% | +188.4% | +119.0% | +35.4% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $1.73B | N/A | -32.2% |
| 3Y | $1.73B | -32.2% | |
| 5Y | $1.73B | -32.2% | |
| All | $1.73B | -32.2% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $1.11B | +5.5% | |
| 3Y | $335.00M | +250.8% | |
| 5Y | $71.00M | +1554.9% | |
| All | -$30.59M | +3941.7% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of ILMN?
As of today, ILMN TTM EBITDA is $1.18B
What is ILMN TTM EBITDA most recent change?
ILMN TTM EBITDA was up +0.86% on March 29, 2026
What is 1-year change in ILMN TTM EBITDA?
ILMN TTM EBITDA is down -32.20% year-over-year
How far is ILMN TTM EBITDA from its all-time high?
ILMN TTM EBITDA is currently -32.20% below its historical high of $1.73B set on March 30, 2025
How does ILMN TTM EBITDA rank versus sector peers?
ILMN TTM EBITDA is higher than 93.56% of companies in Healthcare sector
When is ILMN next earnings release?
The next earnings release for ILMN is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- ILMN Official Website www.illumina.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1110803/000111080326000018/0001110803-26-000018-index.htm
- ILMN Profile on Yahoo Finance finance.yahoo.com/quote/ILMN
- ILMN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/ilmn